Slater Kellee, Bak Thomas E, Kam Igal, Wachs Michael E
University of Colorado Hospital, Denver, Colorado, USA.
Liver Transpl. 2004 Apr;10(4):555-6. doi: 10.1002/lt.20132.
Liver transplantation is now an acceptable treatment for small hepatocellular carcinomas in the setting of cirrhosis. Larger tumors in cirrhotic livers and unresectable tumors in noncirrhotic livers (including fibrolamellar hepatocellular carcinomas) may also be indications for transplantation. With the limited number of cadaver grafts available, living donor liver transplant is becoming an option for some of these patients. We describe a method of reconstruction of the recipient inferior vena cava with deceased donor graft in right lobe living donation for fibrolamellar hepatocellular carcinoma.
肝移植目前是肝硬化背景下小肝细胞癌可接受的治疗方法。肝硬化肝脏中的较大肿瘤以及非肝硬化肝脏中不可切除的肿瘤（包括纤维板层型肝细胞癌）也可能是移植的指征。由于可用的尸体供肝数量有限，活体供肝移植正成为其中一些患者的一种选择。我们描述了一种在右叶活体供肝移植治疗纤维板层型肝细胞癌中，用已故供体移植物重建受体下腔静脉的方法。
